APA (7th ed.) Citation

F, F., ES, B., M, R., A, A., M, M., G, A., . . . S, C. (2026). Adverse hepato-biliary-pancreatic events in acromegaly patients treated with first generation somatostatin receptor ligands. Pituitary, 29(2), . https://doi.org/10.1007/s11102-026-01651-3

Chicago Style (17th ed.) Citation

F, Ferraù, et al. "Adverse Hepato-biliary-pancreatic Events in Acromegaly Patients Treated with First Generation Somatostatin Receptor Ligands." Pituitary 29, no. 2 (2026). https://doi.org/10.1007/s11102-026-01651-3.

MLA (9th ed.) Citation

F, Ferraù, et al. "Adverse Hepato-biliary-pancreatic Events in Acromegaly Patients Treated with First Generation Somatostatin Receptor Ligands." Pituitary, vol. 29, no. 2, 2026, https://doi.org/10.1007/s11102-026-01651-3.